Cargando…
Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial
OBJECTIVE: To investigate cost changes for health systems and participants, resulting from switching to short treatment regimens for multidrug-resistant (MDR) tuberculosis. METHODS: We compared the costs to health systems and participants of long (20 to 22 months) and short (9 to 11 months) MDR tube...
Autores principales: | Madan, Jason J, Rosu, Laura, Tefera, Mamo Girma, van Rensburg, Craig, Evans, Denise, Langley, Ivor, Tomeny, Ewan M, Nunn, Andrew, Phillips, Patrick PJ, Rusen, I D, Squire, S Bertel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265936/ https://www.ncbi.nlm.nih.gov/pubmed/32514196 http://dx.doi.org/10.2471/BLT.19.243584 |
Ejemplares similares
-
Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol
por: Gama, Elvis, et al.
Publicado: (2016) -
Economic evaluation protocol of a short, all-oral bedaquiline-containing regimen for the treatment of rifampicin-resistant tuberculosis from the STREAM trial
por: Rosu, Laura, et al.
Publicado: (2020) -
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial
por: Nunn, Andrew J, et al.
Publicado: (2014) -
Modelling the impact of chest X-ray and alternative triage approaches prior to seeking a tuberculosis diagnosis
por: Shazzadur Rahman, Abu A. M., et al.
Publicado: (2019) -
Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda
por: Rosu, Laura, et al.
Publicado: (2023)